Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- beta-lactamase-producing Enterobacteriaceae

Raquel Palacios-Baena, Zaira; Gutierrez-Gutierrez, Belen; De Cueto, Marina; Viale, Pierluigi; Venditti, Mario; Hernandez-Torres, Alicia; Oliver, Antonio; Martinez-Martinez, Luis; Calbo, Esther; Pintado, Vicente; Gasch, Oriol; Almirante, Benito; Antonio Lepe, Jose; Pitout, Johann; AKOVA, MURAT; Pena-Miralles, Carmen; Schwaber, Mitchell; Tumbarello, Mario; Tacconelli, Evelina; Origuen, Julia; Prim, Nuria; Bou, German; Giamarellou, Helen; Bermejo, Joaquin; Hamprecht, Axel; Perez, Federico; Almela, Manuel; Lowman, Warren; Hsueh, Po-Ren; Navarro-San Francisco, Carolina; Torre-Cisneros, Julian; Carmeli, Yehuda; Bonomo, Robert; Paterson, David; Pascual, Alvaro; Rodriguez-Bano, Jesus

doi:10.1093/jac/dkw513

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- beta-lactamase-producing Enterobacteriaceae

Raquel Palacios-Baena Z., Gutierrez-Gutierrez B., De Cueto M., Viale P., Venditti M., Hernandez-Torres A., ...More

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol.72, no.3, pp.906-913, 2017 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 72 Issue: 3
Publication Date: 2017
Doi Number: 10.1093/jac/dkw513
Journal Name: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.906-913
Open Archive Collection: AVESIS Open Access Collection
Hacettepe University Affiliated: Yes

Abstract

Background. Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality.